Literature DB >> 11028124

I-cell disease (Mucolipidosis II).

M Kabra1, S Gulati, M Kaur, J Sharma, A Singh, V Chopra, P S Menon, V Kalra.   

Abstract

I-cell disease (Mucolipidosis II) is one of the lysosomal storage diseases which presents in the neonatal period, and within six months will phenotypically resemble the severe forms of the group of disorders called the "mucopolysaccharidoses" but without mucopolysacchariduria. In Mucolipidosis II, fibrocytes exhibit "abnormal lysosomes". Activities of several lysosomal enzymes are low in fibroblast cultures but high in mucolipidosis II serum. We present a patient with I-cell disease diagnosed on the basis of clinical, radiological and biochemical features. The mother of this child was pregnant and the fetus was also found to be affected.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11028124     DOI: 10.1007/bf02762185

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  14 in total

1.  I-cell disease: clinical studies of 21 Japanese cases.

Authors:  S Okada; M Owada; T Sakiyama; T Yutaka; M Ogawa
Journal:  Clin Genet       Date:  1985-09       Impact factor: 4.438

2.  Fetal mucolipidosis II (I-cell disease): radiologic and pathologic correlation.

Authors:  D S Babcock; K E Bove; G Hug; P S Dignan; S Soukup; N S Warren
Journal:  Pediatr Radiol       Date:  1986

3.  I-cell disease, mucolipidosis II. Pathological, histochemical, ultrastructural and biochemical observations in four cases.

Authors:  E F Gilbert; G Dawson; G M zu Rhein; J M Opitz
Journal:  Z Kinderheilkd       Date:  1973

4.  Clinical, biochemical, and ultrastructural studies in a case of chondrodystrophy presenting the I-cell phenotype in tissue culture.

Authors:  M Tondeur; E Vamos-Hurwitz; S Mockel-Pohl; J P Dereume; N Cremer; H Loeb
Journal:  J Pediatr       Date:  1971-09       Impact factor: 4.406

5.  Prenatal diagnosis of sialidosis with combined neuraminidase and beta-galactosidase deficiency.

Authors:  W J Kleijer; A Hoogeveen; F W Verheijen; M F Niermeijer; H Galjaard; J S O'Brien; T G Warner
Journal:  Clin Genet       Date:  1979-07       Impact factor: 4.438

6.  I-cell disease. Report of three cases.

Authors:  Y Terashima; K Tsuda; S Isomura; Y Sugiura; H Nogami
Journal:  Am J Dis Child       Date:  1975-09

7.  Mucolipidoses II and III variants with normal N-acetylglucosamine 1-phosphotransferase activity toward alpha-methylmannoside are due to nonallelic mutations.

Authors:  Y Ben-Yoseph; D A Mitchell; R M Yager; J T Wei; T H Chen; L Y Shih
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

8.  Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity.

Authors:  M L Reitman; A Varki; S Kornfeld
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

9.  Inter- and intrafamilial variability in mucolipidosis II (I-cell disease).

Authors:  M Beck; R Barone; R Hoffmann; W Kratzer; T Rakowsky; F Nigro; A Fiumara
Journal:  Clin Genet       Date:  1995-04       Impact factor: 4.438

10.  Mutant enzymatic and cytological phenotypes in cultured human fibroblasts.

Authors:  J G Leroy; R I Demars
Journal:  Science       Date:  1967-08-18       Impact factor: 47.728

View more
  1 in total

1.  Disruption of the Man-6-P targeting pathway in mice impairs osteoclast secretory lysosome biogenesis.

Authors:  Eline van Meel; Marielle Boonen; Haibo Zhao; Viola Oorschot; F Patrick Ross; Stuart Kornfeld; Judith Klumperman
Journal:  Traffic       Date:  2011-05-05       Impact factor: 6.215

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.